AbbVie ABBV Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $3.64B-13.8% | $4.23B-1.8% | $2.42B-52.9% | $3.79B-29.1% | $4.23B-29.6% | ||
| $989M+1.6% | $955M+4.8% | $962M+10.3% | $934M+13.8% | $973M+24.4% | ||
| $21.22B+29.4% | $19.03B+1.2% | $20.86B+26.3% | $19.28B+3.5% | $16.4B-27.7% | ||
| $1.24B+22.4% | $1.21B+24.6% | $1.18B+32.4% | $1.04B+21.7% | $1.02B+27.8% | ||
| —— | —— | —— | —— | —— | ||
| -$6.48B+45.8% | -$6.64B+68.1% | -$7.05B+64.3% | -$12.05B-1.6% | -$11.97B-7.8% | ||
| $11.82B+5.7% | $11.66B+5.7% | $11.5B+5.5% | $11.34B+5.2% | $11.18B+5.0% | ||
| $1.51B+12.1% | $980M-42.6% | $1.34B-1.3% | $1.35B+0.6% | $1.35B+0.3% | ||
| —— | —— | —— | —— | —— | ||
| -$10.55B— | -$12.72B— | -$15.42B— | —— | —— | ||
| $4.22B+133% | -$295M+96.0% | -$1.63B— | -$6.66B— | -$12.89B— | ||
| $19.98B+29.9% | $17.82B-0.1% | $19.68B+26.0% | $18.24B+2.6% | $15.39B-29.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does AbbVie generate?
- AbbVie (ABBV) generated $21.2B in operating cash flow over the trailing twelve months.
- What is AbbVie's free cash flow?
- After $1.2B of capital expenditures, AbbVie's free cash flow was $20.0B over the trailing twelve months, up 29.9% year over year.
- Where does AbbVie's cash flow data come from?
- Every line is extracted from AbbVie's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
